Arizton has Recently Published Two Exclusive Reports on the US Monkeypox Testing Market and Europe Monkeypox Testing Market.
The report considers the present scenario of the US and Europe monkeypox testing markets and the market dynamics for 2023−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
THE US & EUROPE MONKEYPOX TESTING MARKET REPORT SCOPE
|US Monkeypox Testing Market Size (2025)||USD 91 Thousand|
|Europe Monkeypox Testing Market Size (2025)||USD 18,330 Thousand|
|Market Segmentation||Type, End-User, And Geography|
The US Government to Invest in the Future-Ready Diagnostics Segment to Minimize the Monkeypox Cases in the Upcoming Years
The U.S. monkeypox testing market size was valued at $5.3 Million in 2022. The COVID-19 pandemic increased the U.S. healthcare system’s testing capacity and handled outbreaks and pandemics better. The monkeypox virus was diagnosed through the PCR-based method, like the COVID-19 infection testing, and has helped the government immediately increase the testing and provide treatment to the infected people and contribute to the U.S. monkeypox testing market. From day one of this outbreak, providers had access to a high-quality, FDA-cleared test to detect monkeypox.
Download the Free US Monkeypox Testing Market Sample Report: https://www.arizton.com/request-sample/3729
The CDC has scaled the testing capacity to 78 sites in 48 states, primarily at state public health laboratories, with the capacity to conduct around 10,000 tests per week. In addition, CDC began shipping the tests to some of the largest commercial laboratory companies (including some of the nation’s largest reference laboratories) to increase monkeypox testing capacity. This action improved convenience for patients and healthcare providers across the nation, and the government eased the testing procedures by approving the rapid testing kits for monkeypox. The regulatory bodies approved the products faster and increased access to monkeypox testing, further accelerating the U.S. monkeypox testing market.
In addition, the government took better steps to create awareness, communicate among the LGBTQI+ community, mobilize them, and provide better treatments. It was estimated that the U.S. would require USD 7 billion to handle the monkeypox outbreak.
Key Company Profiles: Abbott, F. Hoffmann-La Roche, Qiagen, Thermo Fisher Scientific, Alpha Diagnostic, AtliaBiosystems, Applied DNA Sciences, BioGX, BIONEER, CERTEST BIOTEC, Co-Diagnostics, CorDx, Creative Biogene, Elabscience Biotechnology, LABNOVATION TECHNOLOGIES, and Seegene.
Laboratory-Developed Monkeypox Tests: Aegis Sciences, ARUP Laboratories, Apostle Diagnostics, California Department of Public Health, CDR Companies, CirrusDx, Clinical Reference Laboratory, Devlab Bio, Discover Labs, Integrity Laboratories, Laboratory Corporation of America Holdings, Madison Core Laboratories, Mako Medical Laboratories, Mayo Clinic, Quest Diagnostics, RapidBio, Shepard Health, Sonic Healthcare, US BioTek Laboratories, and UW Virology Laboratory.
Type: PCR, Lateral Flow Assay, and Others
End-User: Laboratories, Hospitals & Clinics, and Others
Geography: The U.S. (Southern, Western, Northeast, and Central)
Increasing Collaborations Among In-Vitro Diagnostic (IVD) Companies Booming the Growth of the Europe Monkeypox Testing Market
The Europe monkeypox testing market size was valued at USD 18.33 million in 2022. The growing development of PCR kits as a standard gold method for monkeypox virus detection is propelling the growth of the Europe monkeypox market. With more than 25,300 confirmed Monkeypox cases in Europe (November 2022), the demand for monkeypox testing is increasing.
Download the Free Europe Monkeypox Testing Market Sample Report: https://www.arizton.com/request-sample/3708
Moreover, the increasing collaborations among In-Vitro Diagnostic (IVD) companies to develop and launch new monkeypox test kits drive market growth. Surprisingly, the ease in medical device regulation only specific for monkeypox encouraged the IVD companies to bring new testing kits into the market and commercialize it, with PCR kits being the gold standard method. Confirmation of MPXV infection is based on nucleic acid amplification testing (NAAT), which uses conventional or real-time PCR to detect unique viral DNA sequences and is widely used as a standard method to detect MPXV. Increasing activities among vendors are driving the Europe monkeypox testing market growth, including the following:
- In July 2022, ELITechGroup, a France-based privately held manufacturer and distributor of IVD equipment, strategically partnered with Jiangsu Bioperfectus Technologies for monkeypox virus testing across Europe.
- In June 2022, Eurobio Scientific launched a CE-marked monkeypox screening test available for hospital use in France.
- On 8th June 2022, altona Diagnostics, a medical diagnostic company headquartered in Germany, announced the launch of the RealStar Zoonotic Orthopoxvirus PCR Kit 1.0, a real-time RT-PCR based reagent system for the detection of zoonotic (non-variola) Orthopoxvirus species-specific DNA – including MPVX DNA of the Central and West African strains.
- On 27th June 2022, Cepheid collaborated with the UK-based global molecular diagnostics company BioGX and announced a partnership between the two companies to provide a PCR test for MPX that will run on the GeneXpert system.
- In July, the altona Diagnostics company launched another monkeypox virus detection kit, Flexstar Monkeypox Virus PCR Detection Mix 1.5, for research purposes.
- Bioactiva Diagnostica is another Germany-based company that offers PCR kits for monkeypox virus detection.
Key Company Profiles:
Hoffmann-La Roche, Qiagen, altona Diagnostics, Autobio, Applied DNA Sciences, Aurora Biomed, bioactiva diagnostica, Beijing Hotgen Biotech, BioGX, CERTEST BIOTEC, Creative Biogene, CorDx, CLONIT, Eurobio Scientific, FireGene, GenScript, Guangzhou Pluslife Biotech, JOYSBIO (Tianjin) Biotechnology, Nanjing Synthgene Medical Technology, RayBiotech Life, Sansure Biotech, Virax Biolabs, Wondfo, and Shanghai Biogerm Medical Technology
- Type: PCR, Lateral Flow Assay, and Others
- End-User: Laboratories, Hospitals & Clinics, and Others
- Geography: Europe [EU-5 (Spain, France, UK, Germany, and Italy), Central and Eastern Europe (Netherlands, Portugal, and Switzerland), and Nordic (Sweden and Denmark)]
In Vitro Diagnostics Market – Global Outlook & Forecast 2023-2028
HIV Rapid Test Kits Market – Global Outlook & Forecast 2023-2028
COVID-19 Rapid Antigen Test Kits Market – Global Outlook & Forecast 2022-2027
Hematology Diagnostics Market – Global Outlook & Forecast 2022-2027
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
+1 302 469 0707
Contact Us: https://www.arizton.com/contact-us